医薬品ADMET試験の2028年までの市場予測-試験タイプ、技術、アプリケーション別の世界分析

医薬品ADMET試験市場は、2021年の67億8,306万米ドルから2028年には135億7,862万米ドルに成長すると予測され、2022年から2028年までのCAGRは10.5%と推定されています。

本レポートでは、市場に蔓延する動向と市場成長を促進する要因について取り上げています。市場成長の背景には、後発医薬品の失敗率が高いこと、製品の承認・上市数が増加していることが挙げられます。さらに、新規および新興技術の台頭は、予測期間中に市場の重要な動向として現れると思われます。しかし、ADME試験研究のコストが高いことが、市場の成長を制限しています。

ADMET（吸収、分布、代謝、排泄、毒性）試験は、薬の薬物動態学的および薬力学的特性を理解するために、創薬および開発において重要な役割を担っています。この試験により、創薬段階での薬物失敗の可能性を防ぐことができます。このように、ADMET試験は、製薬会社が創薬期間、試験の複雑さ、および薬剤開発コストを最小限に抑えることを容易にします。

医薬品の承認前段階の支出は25億6000万米国ドル、承認後の段階ではさらに28億7000万米国ドルに増加します。2022年、「臨床医薬品開発の90%が失敗する理由とその改善方法」と題された研究によると、多くの戦略を成功裏に実施したにもかかわらず、臨床医薬品開発の90%は失敗しています。臨床試験に入った後、第I相、第II相、第III相の臨床試験、医薬品承認プロセスで、10人中9人の医薬品候補が失敗します。前臨床段階で却下された医薬品候補は、第I相臨床試験に入らないため、臨床段階での失敗率90％には含まれないです。前臨床段階の医薬品候補を含めると、創薬開発の失敗率は90%よりさらに高くなります。2010年から2017年までの臨床試験データの分析によると、臨床効果の不足（40～50％）、制御不能な毒性（30％）、薬剤的品質の低さ（10～15％）、商業的ニーズがない、効果的な戦略計画の欠如（10％）が試験失敗の4大原因とされています。

新薬開発は資源と時間の両方が必要であり、後期の臨床ステージでは多大なコストがかかります。臨床使用が承認される新薬の発見と開発には、長く、高価で、困難なプロセスが必要であり、10～15年以上かかり、平均して1億2,000万米ドル以上のコストがかかっています。医薬品の研究開発における廃棄率を下げるためには、医薬品の吸収、分布、代謝、排泄、毒性（ADMET）特性を早い段階でフィルタリングし、最適化することが極めて重要です。創薬の臨床段階での失敗率を減らすために、医薬品のADMET特性をできるだけ早い段階で考慮すべきであることは広く認められています。In vitroおよびin vivoの医薬品評価技術は前臨床応用において成熟期に達しており、in silico技術は前臨床段階で医薬品の関連特性を評価するために広く受け入れられるようになってきています。ソフトウェアプログラムおよびin silicoモデルの開発は、ADMET試験の実施をさらに促進しています。このように、医薬品開発におけるADME試験のニーズの高まりが、医薬品ADMET試験市場を後押ししています。

試験タイプに基づき、医薬品ADMET試験市場は、in vivo ADMET試験、in vitro ADMET試験、in silico ADMET試験に区分されます。2021年では、in vivo ADMET試験分野が最大の市場シェアを占めています。しかし、2022年から2028年にかけては、in vitro ADMETテストセグメントが最も高いCAGRを記録すると予想されます。技術に基づき、医薬品ADMET試験市場は、細胞培養、ハイスループット、分子イメージング、およびOMICS技術に区分されます。2021年には、細胞培養セグメントが最大の市場シェアを占めています。しかし、ハイスループット分野は予測期間中に最も高いCAGRを記録すると予想されます。用途に基づき、医薬品ADMET試験市場は、全身毒性、腎臓毒性、肝毒性、神経毒性、その他に区分されます。2021年には、全身毒性セグメントが最大の市場シェアを占めました。しかし、肝毒性セグメントは2022-2028年の間に最も高いCAGRを記録すると予測されています。

COVID-19パンデミックが製薬ADMET試験市場に与える影響

COVID-19パンデミックは、APAC全体で研究者の数が増加したため、医薬品ADMET試験市場にプラスの影響を与えました。パンデミックの間、いくつかの医薬品やワクチンを研究するために、in vitro毒性試験の需要が増加しました。さらに、研究数の増加により、新型コロナウイルスの蔓延を防ぐために、人的資源に代わって技術の活用が進みました。このように、技術分野は指数関数的に成長しました。さらに、APAC諸国の政府は、COVID-19に対する革新的な医薬品を開発するために、研究者向けのプログラムやオープン課題のイベントを開催しました。このようなイベントは、政府資金の増加により、全体の研究件数を増加させました。このように、上記の事実は、COVID-19の流行が医薬品ADMET試験市場にプラスの影響を与えることを示しています。

医薬品ADMET試験市場では、さまざまな有機的および無機的戦略が企業によって採用されています。有機的戦略は、主に製品の発売と製品承認を含みます。さらに、市場で示された無機的な成長戦略は、買収、共同研究、およびパートナーシップです。これらの成長戦略により、市場参加者は事業を拡大し、地理的プレゼンスを高めることができ、それによって市場全体の成長に貢献することができます。さらに、買収とパートナーシップ戦略は、顧客基盤を強化し、製品ポートフォリオを拡大する上で、市場プレイヤーを支援します。医薬品ADMET試験市場における主要企業の重要な発展のいくつかを以下に示します。

2022年4月、チャールズリバーラボラトリーズは、革新的な治療薬の発見に向けて創薬プロジェクトを推進するため、NCLとの提携を発表しました。NLCは、その広範なバイオテクノロジーと製薬のエコシステムと知識を活用し、ポテンシャルの高い前臨床バイオテクノロジー研究を厳選しています。チャールズリバーの包括的な前臨床開発サービスと戦略リソースは、安全で高品質な創薬と開発を提供し、患者さんの命を救う薬を届けるためにNLCのポートフォリオ企業のプロジェクトを一緒に支えています。

2022年3月、プロメガ・コーポレーション（以下、プロメガ）は、富士フイルムセルラーダイナミクス株式会社との間で、創薬のための新規アッセイ開発を推進するための協業を発表しました。富士フイルムセルラーダイナミクスは、複数年のライセンス契約のもと、創薬プロセスにおける新規アッセイ開発の一環として、プロメガのバイオセンサーおよび細胞内生物発光レポーター機能を統合したカスタム分化誘導多能性幹細胞（iPSC）を研究者や科学者に幅広く提供します。

カナダ革新財団（CFI）、オーストラリア研究会議（ARC）、国立衛生研究所（NIH）、世界保健機関（WHO）、疾病管理センター（CDC）、英国製薬工業協会（ABPI）は、医薬品ADMET試験市場に関するレポートを作成するにあたって参照した主な一次および二次情報のほんの一部です。

目次

第1章 イントロダクション

• 調査対象範囲
• インサイトパートナーズの調査報告書ガイダンス
• 市場セグメンテーション
  • 医薬品ADMET試験の世界市場- 試験タイプ別
  • 医薬品ADMET試験の世界市場- 技術別
  • 医薬品ADMET試験の世界市場：用途別
  • 医薬品ADMET試験の世界市場- 地域別

第2章 医薬品ADMET試験の市場-主要なポイント

第3章 調査手法

• 対象範囲
• 2次調査
• 1次調査

第4章 医薬品ADMET試験の世界市場情勢- 市場展望

• PEST分析
  • 北米のPEST分析
  • 欧州-PEST分析
  • アジア太平洋-PEST分析
  • 中東・アフリカのPEST分析
  • 中南米-PEST分析
• 専門家の見解

第5章 医薬品ADMET試験市場- 主な市場力学

• 市場促進要因
  • 後発医薬品の失敗率の高さ
  • 製品の承認と上市の増加
• 市場抑制要因
  • ADME試験研究の高コスト
• 市場機会
  • ADME試験の自動化と進歩
• 今後の動向
  • ハイスループット・スクリーニングの登場
• インパクト分析

第6章 医薬品ADMET試験市場-世界分析

• 医薬品ADMET試験の世界市場収益と予測・分析
• 医薬品ADME試験の世界市場、地域別予測・分析
• 主要プレイヤーの市場ポジショニング
• 医薬品ADME試験の世界市場-地域別市場ポテンシャル分析
• 比較企業分析
• 成長戦略分析
• 主要プレイヤーの業績
  • WuXi AppTec
  • チャールズ・リバー・ラボラトリーズ・インク

第7章 医薬品ADMET試験市場の分析と2028年までの予測- 試験タイプ別

• 医薬品ADMET試験の世界市場、試験タイプ別2022年・2028年（%）
• In Vivo ADMET試験
• In Vitro ADMET試験
• インシリコADMET試験

第8章 医薬品ADMET試験の市場分析と2028年までの予測-技術別

• 医薬品ADMET試験の世界市場、技術別2022年・2028年（%）
• 細胞培養
• ハイスループット
• 分子イメージング
• オミックス技術

第9章 医薬品ADMET試験の世界市場分析-用途別

• 医薬品ADMET試験の世界市場：用途別2022年・2028年（%）
• 全身毒性
• 腎毒性
• 肝毒性
• 神経毒性
• その他

第10章 医薬品ADMET試験市場の収益と2028年までの予測-地域別分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域
  • UAE
  • サウジアラビア
  • 南アフリカ
  • その他中東・アフリカ地域
• 中南米地域
  • 中南米地域
    • ブラジル
    • アルゼンチン
    • その他の中南米地域

第11章 COVID-19のパンデミックが医薬品ADMET試験市場に与える影響

• 北米
• 欧州
• アジア太平洋地域
• 中東とアフリカ
• 中南米

第12章 医薬品ADMET試験市場-業界情勢

• 市場参加企業が行った成長戦略（%）
• 有機的な発展
• インオーガニック開発

第13章 企業プロファイル

• CMIC HOLDINGS Co., LTD
• Charles River Laboratories
• WuXi AppTec
• Promega Corporation
• Sigma-Aldrich（MERCK KGaA）
• Agilent Technologies, Inc.
• Biovia（Dassault Systemes）
• Cyprotex Limited
• Bio-Rad Laboratories, Inc.
• IQVIA Inc.

第14章 付録

• The Insight Partners について
• 用語解説

List Of Tables

• Table 1. North America Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 2. North America Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (USD Million)
• Table 3. North America Pharma ADMET Testing Market, by Application- Revenue and Forecast to 2028 (US$ Million)
• Table 4. US Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 5. US Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 6. US Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 7. Canada: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 8. Canada Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 9. Canada Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 10. Mexico: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 11. Mexico Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 12. Mexico Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 13. Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 14. Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 15. Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 16. Germany: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 17. Germany: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 18. Germany: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 19. UK: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 20. UK: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 21. UK: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 22. France: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 23. France: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 24. France: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 25. Italy: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 26. Italy: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 27. Italy: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 28. Spain: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 29. Spain: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 30. Spain: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 31. Rest of Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 32. Rest of Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
• Table 33. Rest of Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 34. Asia Pacific: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 35. Asia Pacific: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 36. Asia Pacific: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 37. China: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 38. China: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 39. China: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 40. Japan: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 41. Japan: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 42. Japan: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 43. India: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 44. India: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 45. India: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 46. South Korea: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 47. South Korea: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 48. South Korea: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 49. Australia: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 50. Australia: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 51. Australia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 52. Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
• Table 53. Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 54. Rest of Asia Pacific: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 55. Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
• Table 56. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 57. Middle East & Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 58. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
• Table 59. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 60. UAE: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 61. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
• Table 62. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 63. Saudi Arabia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 64. South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
• Table 65. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 66. South Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 67. Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
• Table 68. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
• Table 69. Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• Table 70. South and Central America: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
• Table 71. South and Central America: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
• Table 72. South and Central America: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
• Table 73. Brazil: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
• Table 74. Brazil: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
• Table 75. Brazil: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
• Table 76. Argentina: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
• Table 77. Argentina: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
• Table 78. Argentina: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
• Table 79. Rest of South and Central America: Pharma ADMET Testing Market, by Type - Revenue and Forecast to 2028 (USD Million)
• Table 80. Rest of South and Central America: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
• Table 81. Rest of South and Central America: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
• Table 82. Organic Developments Done by Companies
• Table 83. Inorganic Developments Done by Companies
• Table 84. Glossary of Terms

List Of Figures

• Figure 1. Pharma ADMET Testing Market Segmentation
• Figure 2. Pharma ADMET Testing Market, By Region
• Figure 3. Global Pharma ADMET Testing Market Overview
• Figure 4. In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in Pharma ADMET Testing Market
• Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
• Figure 6. Pharma ADMET Testing Market, by Geography (US$ Million)
• Figure 7. Global Pharma ADMET Testing Market - Leading Country Markets (US$ Million)
• Figure 8. Global Pharma ADMET Testing Market, Industry Landscape
• Figure 9. North America: PEST Analysis
• Figure 10. Europe: PEST Analysis
• Figure 11. Asia Pacific: PEST Analysis
• Figure 12. Middle East & Africa: PEST Analysis
• Figure 13. South & Central America: PEST Analysis
• Figure 14. Pharma ADMET Testing Market Impact Analysis of Driver and Restraints
• Figure 15. Global Pharma ADME Testing Market- Revenue Forecast and Analysis - 2022 - 2028
• Figure 16. Global Pharma ADME Testing Market - By Geography Forecast and Analysis - 2022 - 2028
• Figure 17. Market Positioning of Key Players in Pharma ADME Testing Market
• Figure 18. Global Pharma ADME Testing Market - Market Potential Analysis, By Region
• Figure 19. Global Pharma ADME Testing Market - Comparative Company Analysis
• Figure 20. Global Pharma ADME Testing Market - Growth Strategy Analysis
• Figure 21. Global Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)
• Figure 22. In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
• Figure 23. In Vitro ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
• Figure 24. In Silico ADMET Testing Revenue and Forecasts to 2028 (US$ Million)
• Figure 25. Global Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)
• Figure 26. Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 27. High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 28. Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 29. OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 30. Global Pharma ADMET Testing Market, by Application 2022 & 2028 (%)
• Figure 31. Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• Figure 32. Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• Figure 33. Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• Figure 34. Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• Figure 35. Others - Revenue And Forecasts To 2028 (US$ Million)
• Figure 36. North America: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 37. North America Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
• Figure 38. North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
• Figure 39. US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 40. Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 41. Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 42. Europe: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 43. Europe: Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
• Figure 44. Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
• Figure 45. Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 46. UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 47. France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 48. Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 49. Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 50. Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 51. Asia Pacific Pharma ADMET Testing Market Overview, by Country (2022)
• Figure 52. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 53. Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
• Figure 54. China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 55. Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 56. India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 57. South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 58. Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 59. Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 60. Middle East & Africa Pharma ADMET Testing Market Revenue Overview, by Country, 2022 (US$ Million)
• Figure 61. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 62. Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
• Figure 63. UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 64. Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 65. South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 66. Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
• Figure 67. South and Central America: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$' Million)
• Figure 68. South and Central America Pharma ADMET Testing Market Revenue and Forecast to 2028 (USD Million)
• Figure 69. South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
• Figure 70. Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
• Figure 71. Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
• Figure 72. Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
• Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
• Figure 74. Impact of COVID-19 Pandemic in European Country Markets
• Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
• Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
• Figure 77. Impact of COVID-19 Pandemic in South and Central American Countries
• Figure 78. Growth Strategies Done by the Companies in the Market, (%)

The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the high rate of late-stage drug failure and the increasing number of products approvals and launches. Additionally, the rise of new and emerging technologies is likely to emerge as a significant trend in the market during the forecast period. However, the high cost of ADME testing studies limits the market growth.

ADMET (absorption, distribution, metabolism, excretion, and toxicology) testing plays a critical role in drug discovery and development to understand the pharmacokinetic and pharmacodynamic properties of a drug. The testing prevents the chances of drug failure during the drug discovery phase. Thus, ADMET testing facilitates pharmaceutical companies to minimize drug discovery time, testing complications, and drug development cost.

The pre-approval expenditures for a medicine can be as high as US$ 2.56 billion, which further increases to US$ 2.87 billion in the post-approved stage. According to the study titled "Why 90% of Clinical Drug Development Fails and How to Improve It?", 2022, 90% of clinical drug development fails despite the successful implementation of many strategies. After entering clinical investigations, 9 out of 10 drug candidates fail during phase I, II, and III clinical trials, and the drug approval process. Drug candidates rejected in preclinical stages are not included in the 90% failure rate of the drugs in clinical stages, as they don't enter the phase I clinical trials. If preclinical drug candidates are included, the failure rate of drug discovery and development rises even higher than 90%. According to analyses of clinical trial data from 2010 to 2017, lacking clinical effectiveness (40-50%), uncontrollable toxicity (30%), poor drug-like qualities (10-15%), no commercial needs, and ineffective strategic planning (10%) are the four major causes of trial failure.

New drug development is both resource and time-intensive, where later clinical stages result in significant costs. The discovery and development of each new medicine that is approved for clinical use is a lengthy, expensive, and challenging process that takes over 10-15 years and costs on average over US$ 1-2 billion. To lower the attrition rate in drug research & development, it is crucial to filter and optimize the absorption, distribution, metabolism, elimination, and toxicity (ADMET) characteristics of pharmaceuticals at an early stage. It has been widely accepted that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. In vitro and in vivo drug evaluation techniques have reached maturity in preclinical applications, and in silico technologies are gaining vast acceptance to evaluate the relevant properties of drugs in the preclinical stage. The development of software programs and in silico models is further promoting the implementation of ADMET studies. Thus, the increasing need for ADME testing in drug development boosts the pharma ADMET testing market.

Based on testing type, the pharma ADMET testing market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In 2021, the in vivo ADMET testing segment holds the largest market share. However, the in vitro ADMET testing segment is expected to register the highest CAGR from 2022 to 2028. Based on technology, the pharma ADMET testing market is segmented into cell culture, high throughput, molecular imaging, and OMICS technology. The cell culture segment held the largest market share in 2021. However, the high throughput segment is anticipated to register the highest CAGR during the forecast period. Based on application, the pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. The systemic toxicity segment held the largest market share in 2021. However, the hepatotoxicity segment is anticipated to register the highest CAGR during 2022-2028.

Impact of COVID-19 Pandemic on Pharma ADMET Testing Market

The COVID-19 pandemic positively impacted the pharma ADMET testing market due to the increased number of researchers across APAC. During the pandemic, the demand for in vitro toxicology studies increased to study several drugs and vaccines. Additionally, the increased number of researches led to high utilization of technology instead of human resource to prevent the spread of novel coronavirus. Thus, the technology segment grew at an exponential level. Moreover, governments of APAC countries organized programs and open challenge events for researchers to come up with innovative drugs for COVID-19. Such events increased the overall research numbers due to the rise in government funding. Thus, the above-mentioned facts indicate the positive impact of COVID-19 pandemic on the pharma ADMET testing market.

Various organic and inorganic strategies are adopted by companies in the pharma ADMET testing market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players in strengthening their customer base and expanding their product portfolios. A few of the significant developments by key players in the pharma ADMET testing market are listed below.

In April 2022, Charles River Laboratories announced a collaboration with NCL to drive drug discovery projects toward finding innovative therapeutics. NLC utilizes its extensive biotech and pharmaceutical ecosystem and knowledge to carefully select high-potential, preclinical biotech research. Charles River's comprehensive preclinical development services and strategy resources provide safe, high-quality drug discovery and development, which is supporting the projects of NLC's portfolio companies together to bring life-saving drugs to patients.

In March 2022, Promega Corporation (Promega) announced a collaboration with FUJIFILM Cellular Dynamics, Inc., for advancing novel assay development for drug discovery. Under a multi-year licensing agreement, FUJIFILM Cellular Dynamics will offer a wide range of custom differentiated induced pluripotent stem cell (iPSCs) integrated with Promega biosensor and intracellular bioluminescent reporter capabilities for researchers and scientists to use as a part of novel assay development in the drug discovery process.

The Canada Foundation for Innovation (CFI), Australian Research Council (ARC), National Institute of Health (NIH), World Health Organization (WHO), the Centers for Disease Control (CDC), and the Association of the British Pharmaceutical Industry (ABPI) are a few of the major primary and secondary sources referred to while preparing the report on the pharma ADMET testing market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pharma ADMET testing market.
• Highlights key business priorities and focus in order to assist companies to realign their business strategies.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Global Pharma ADMET Testing Market - By Testing Type
  • 1.3.2 Global Pharma ADMET Testing Market - By Technology
  • 1.3.3 Global Pharma ADMET Testing Market - By Application
  • 1.3.4 Global Pharma ADMET Testing Market - By Geography

2. Pharma ADMET Testing Market- Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Global Pharma ADMET Testing Market - Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 North America - PEST Analysis
  • 4.2.2 Europe - PEST Analysis
  • 4.2.3 Asia Pacific - PEST Analysis
  • 4.2.4 Middle East & Africa - PEST Analysis
  • 4.2.5 South & Central America - PEST Analysis
• 4.3 Expert Opinion

5. Pharma ADMET Testing Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 High Rate of Late-Stage Drug Failure
  • 5.1.2 Increasing Number of Product Approvals and Launches
• 5.2 Market Restraints
  • 5.2.1 High Cost of ADME Testing Studies
• 5.3 Market Opportunities
  • 5.3.1 Automation and Advancements in ADME Testing
• 5.4 Future Trends
  • 5.4.1 The Advent of High-Throughput Screening
• 5.5 Impact Analysis

6. Pharma ADMET Testing Market- Global Analysis

• 6.1 Global Pharma ADMET Testing Market Revenue Forecast and Analysis
• 6.2 Global Pharma ADME Testing Market, By Geography - Forecast, and Analysis
• 6.3 Market Positioning of Key Players
• 6.4 Global Pharma ADME Testing Market - Market Potential Analysis, By Region
• 6.5 Comparative Company Analysis
• 6.6 Growth Strategy Analysis
• 6.7 Performance of Key Players
  • 6.7.1 WuXi AppTec
  • 6.7.2 Charles River Laboratories Inc.

7. Pharma ADMET Testing Market Analysis And Forecasts To 2028 - By Testing Type

• 7.1 Overview
• 7.2 Global Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)
• 7.3 In Vivo ADMET Testing
  • 7.3.1 Overview
  • 7.3.2 In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
• 7.4 In Vitro ADMET Testing
  • 7.4.1 Overview
  • 7.4.2 In Vitro ADMET Testing Revenue and Forecast to 2028 (US$ Million)
• 7.5 In Silico ADMET Testing
  • 7.5.1 Overview
  • 7.5.2 In Silico ADMET Testing Revenue and Forecast to 2028 (US$ Million)

8. Pharma ADMET Testing Market Analysis And Forecasts To 2028 - By Technology

• 8.1 Overview
• 8.2 Global Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)
• 8.3 Cell Culture
  • 8.3.1 Overview
  • 8.3.2 Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)
• 8.4 High Throughput
  • 8.4.1 Overview
  • 8.4.2 High Throughput - Market Revenue and Forecast to 2028 (US$ Million)
• 8.5 Molecular Imaging
  • 8.5.1 Overview
  • 8.5.2 Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)
• 8.6 OMICS Technology
  • 8.6.1 Overview
  • 8.6.2 OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)

9. Global Pharma ADMET Testing Market Analysis- By Application

• 9.1 Overview
• 9.2 Global Pharma ADMET Testing Market, By Application 2022 & 2028 (%)
• 9.3 Systemic Toxicity
  • 9.3.1 Overview
  • 9.3.2 Systemic Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• 9.4 Renal Toxicity
  • 9.4.1 Overview
  • 9.4.2 Renal Toxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• 9.5 Hepatotoxicity
  • 9.5.1 Overview
  • 9.5.2 Hepatotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• 9.6 Neurotoxicity
  • 9.6.1 Overview
  • 9.6.2 Neurotoxicity - Market Revenue And Forecasts To 2028 (US$ Million)
• 9.7 Others
  • 9.7.1 Overview
  • 9.7.2 Others - Revenue And Forecasts To 2028 (US$ Million)

10. Pharma ADMET Testing Market Revenue and Forecasts to 2028 - Geographical Analysis

• 10.1 North America: Pharma ADMET Testing Market
  • 10.1.1 Overview
  • 10.1.2 North America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.1.3 North America: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
  • 10.1.4 North America: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
  • 10.1.5 North America: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
  • 10.1.6 North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
    • 10.1.6.1 US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.1.1 Overview
      • 10.1.6.1.2 US: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.1.3 US: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
      • 10.1.6.1.4 US: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
      • 10.1.6.1.5 US: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
    • 10.1.6.2 Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.2.1 Overview
      • 10.1.6.2.2 Canada: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.2.3 Canada: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
      • 10.1.6.2.4 Canada: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
      • 10.1.6.2.5 Canada: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
    • 10.1.6.3 Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.3.1 Overview
      • 10.1.6.3.2 Mexico: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.6.3.3 Mexico: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)
      • 10.1.6.3.4 Mexico: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)
      • 10.1.6.3.5 Mexico: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)
• 10.2 Europe: Pharma ADMET Testing Market
  • 10.2.1 Overview
  • 10.2.2 Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.2.3 Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
  • 10.2.4 Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • 10.2.5 Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • 10.2.6 Europe: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
    • 10.2.6.1 Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.1 Germany: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.2 Germany: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.3 Germany: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.4 Germany: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6.2 UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.1 UK: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.2 UK: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.3 UK: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.4 UK: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6.3 France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.1 France: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.2 France: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.3 France: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.4 France: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6.4 Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.1 Italy: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.2 Italy: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.3 Italy: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.4 Italy: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6.5 Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.1 Spain: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.2 Spain: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.3 Spain: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.4 Spain: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.6.6 Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.1 Rest of Europe: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.2 Rest of Europe: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.3 Rest of Europe: Pharma ADMET Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.4 Rest of Europe: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• 10.3 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts To 2028
  • 10.3.1 Overview
  • 10.3.2 Asia Pacific Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • 10.3.3 Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
  • 10.3.4 Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
  • 10.3.5 Asia Pacific: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
  • 10.3.6 Asia Pacific: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
    • 10.3.6.1 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.1.1 Overview
      • 10.3.6.1.2 China: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.1.3 China: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.1.4 China: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.1.5 China: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.2.1 Overview
      • 10.3.6.2.2 Japan: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.2.3 Japan: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.2.4 Japan: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.2.5 Japan: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6.3 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.3.1 Overview
      • 10.3.6.3.2 India: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.3.3 India: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.3.4 India: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.3.5 India: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6.4 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.4.1 Overview
      • 10.3.6.4.2 South Korea: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.4.3 South Korea: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.4.4 South Korea: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.4.5 South Korea: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6.5 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.5.1 Overview
      • 10.3.6.5.2 Australia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.3.6.5.3 Australia: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.5.4 Australia: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.5.5 Australia: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
    • 10.3.6.6 Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6.1 Overview
      • 10.3.6.6.2 Rest of Asia Pacific: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6.3 Rest of Asia Pacific: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (US$ Million)
      • 10.3.6.6.4 Rest of Asia Pacific: Pharma ADMET Testing Market, by Technology, 2019-2028 (US$ Million)
      • 10.3.6.6.5 Rest of Asia Pacific: Pharma ADMET Testing Market, by Application, 2019-2028 (US$ Million)
• 10.4 Middle East & Africa: Pharma ADMET Testing Market
  • 10.4.1 Overview
  • 10.4.2 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • 10.4.3 Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
  • 10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • 10.4.5 Middle East & Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • 10.4.6 Middle East & Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)
    • 10.4.6.1 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.1.1 Overview
      • 10.4.6.1.2 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.1.3 UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
      • 10.4.6.1.4 UAE: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
      • 10.4.6.1.5 UAE: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.2.1 Overview
      • 10.4.6.2.2 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.2.3 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
      • 10.4.6.2.4 Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts To 2028, By Technology (US$ Million)
      • 10.4.6.2.5 Saudi Arabia: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.3.1 Overview
      • 10.4.6.3.2 South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.3.3 South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
      • 10.4.6.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
      • 10.4.6.3.5 South Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6.4 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.4.1 Overview
      • 10.4.6.4.2 Rest of Middle East and Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)
      • 10.4.6.4.3 Rest of Middle East & Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)
      • 10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)
      • 10.4.6.4.5 Rest of Middle East and Africa: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
• 10.5 South & Central America: Pharma ADMET Testing Market
  • 10.5.1 Overview
  • 10.5.2 South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
  • 10.5.3 South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
  • 10.5.4 South and Central America: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
  • 10.5.5 South and Central America: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
  • 10.5.6 South and Central America: Pharma ADMET Testing Market, by country, 2021 & 2028 (%)
    • 10.5.6.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.1.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.1.2 Brazil: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
      • 10.5.6.1.3 Brazil: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
      • 10.5.6.1.4 Brazil: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
    • 10.5.6.2 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.2.1 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.2.2 Argentina: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
      • 10.5.6.2.3 Argentina: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
      • 10.5.6.2.4 Argentina: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
    • 10.5.6.3 Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.3.1 Rest of South and Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.3.2 Rest of South and Central America: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
      • 10.5.6.3.3 Rest of South and Central America: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
      • 10.5.6.3.4 Rest of South and Central America: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on Pharma ADMET Testing Market

• 11.1 North America: Impact Assessment of COVID-19 Pandemic
• 11.2 Europe: Impact Assessment of COVID-19 Pandemic
• 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
• 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
• 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharma ADMET Testing Market-Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies Done by the Companies in the Market, (%)
• 12.3 Organic Developments
  • 12.3.1 Overview
• 12.4 Inorganic Developments
  • 12.4.1 Overview

13. Company Profiles

• 13.1 CMIC HOLDINGS Co., LTD
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Charles River Laboratories
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 WuXi AppTec
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Promega Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Sigma-Aldrich (MERCK KGaA)
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Agilent Technologies, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Biovia (Dassault Systemes)
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 Cyprotex Limited
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Bio-Rad Laboratories, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 IQVIA Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms